Description
An orally bioavailable CGRP receptor antagonist (Ki = 0.027 nM); inhibits α-CGRP-stimulated cAMP production in SK-N-MC human neuroblastoma cells (IC50 = 0.14 nM); reduces human α-CGRP-induced increases in facial blood flow, a surrogate for changes in intracranial artery diameter, in anesthetized marmosets at 7 mg/kg
Formal name: 4-(2,3-dihydro-2-oxo-1H-imidazo[4,5-b]pyridin-1-yl)-1-piperidinecarboxylic acid, (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl ester
Synonyms: BMS-927711
Molecular weight: 534.6
CAS: 1289023-67-1
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Cardiovascular System|Cardiovascular Diseases||Research Area|Cardiovascular System|Vasculature|Vasoconstriction||Research Area|Neuroscience|Pain Research